Pediatric HIV Costs Across Three Treatment Eras from 1986 to 2007

Pediatrics

Volumn 126, Issue 3, 2010, Pages

  Wilson, Leslie S ^a,b   Basu, Rituparna ^b   Christenson, Maria ^b   Hensic, Lori ^b   Paoli, Carly ^b   Wara, Diane ^a   Moskowitz, Judith T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiretroviral therapy; Cost; Cost analysis; Cost effectiveness analysis; Hiv aids pediatrics; IMPAACT; Public policy

Indexed keywords

ANTIVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BOOTSTRAPPING; CHILD; COST CONTROL; DISEASE TRANSMISSION; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRAVENOUS DRUG ABUSE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; NEWBORN; OUTPATIENT CARE; PEDIATRICS; PRENATAL EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCIENTIFIC LITERATURE; COST OF ILLNESS; ECONOMICS; HIV INFECTIONS; PRESCHOOL CHILD; TIME;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; REGRESSION ANALYSIS; TIME FACTORS;

EID: 77956287690     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-3485     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2007. Vol 19. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. Available at: www.cdc.gov/hiv/topics/ surveillance/resources/reports. Accessed February 28, 2010
2. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173-1180
3. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-Infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484-494
4. Sharma D, Spearman P. The impact of cesarean delivery on transmission of infectious agents to the neonate. Clin Perinatol. 2008;35(2):407-420 (Pubitemid 351626128)
5. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998;339(20):1409-1414
6. Kourtis AP, Bansil P, Posner SF, Johnson C, Jamieson DJ. Trends in hospitalizations of HIV-Infected children and adolescents in the United States: analysis of data from the 1994-2003 Nationwide Inpatient Sample. Pediatrics. 2007;120(2). Available at: www.pediatrics.org/cgi/content/full/120/2/e236
7. Patel K, Hernán MA, Williams PL, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis. 2008; 46(4):507-515 (Pubitemid 351263487)
8. Viani RM, Araneta MR, Deville JG, Spector SA. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2004;39(5):725-731
9. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Atlanta, GA: Centers for Disease Control and Prevention; 2009:1-139. Available at: www.aidsinfo.nih.gov/contentfiles/ pediatricguidelines.pdf. Accessed July 2, 2010
10. Healthcare Cost and Utilization Project (HCUP). Overview of the Kids' Inpatient Database (KID). Rockville, MD: Agency for Healthcare Research and Quality; 2008. Available at: www.hcup-us.ahrq.gov/kidoverview.jsp. Accessed March 8, 2010
11. Davis JB. Medical Fees in the United States, 2007. Los Angeles, CA: Practice Management Information Corporation; 2007
12. United States Bureau of Labor Statistics. Databases, Tables and Calculators by Subject: Inflation and Prices. Washington, DC: US Department of Labor. Available at: www.bls.gov/data. Accessed January 6, 2009
13. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23(3):525-542
14. Greene WH. Econometric Analysis. 6th ed. Upper Saddle River, NJ: Prentice Hall; 2007
15. Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge MA: MIT Press; 2002
16. Fox J. Bootstrapping Regression Models: Appendix to an R and S-PLUS Companion to Applied Regression, January 2002. Available at: http://cran.r-project.org/doc/contrib/Fox-Companion/appendix-bootstrapping.pdf. Accessed March 11, 2010
17. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1994-1996. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. Available at: www.cdc.gov/hiv/topics/ surveillance/resources/reports/pdf/hiivsur62.pdf. Accessed February 28, 2010
18. Davis SF, Byers RH Jr, Lindegren ML, Caldwell MB, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA. 1995;274(12):952-955
19. Centers for Disease Control and Prevention, HIV/AIDS Surveillance Report, 2006. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention. 2006;18:1-55. Available at: www.cdc.gov/hiv/ topics/surveillance/resources/reports/2006report/pdf/2006SurveillanceReport.pdf. Accessed June 26, 2010
20. Silverman LB, Sallan SE. Newly diagnosed childhood ALL: update on prognostic factors and treatment. Curr Opin Hematol. 2003;10(4):290-296
21. Sansom SL, Anderson JE, Farnham PG. Updated estimates of healthcare utilization and costs among perinatally HIV-infected children. J Acquir Immune Defic Syndr. 2006;41(4):521-526
22. Fleishman JA, Hellinger FJ. Trends in HIV-related inpatient admissions from 1993 to 1997: a seven-state study. J Acquir Immune Defic Syndr. 2001;28(1):73-80
23. Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344(11):817-823